Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 4 recruiting now small index

PrEP clinical trials

4 of 6 indexed PrEP trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 4 currently recruiting · #2,866 of 28,707 conditions by registered trial count

PrEP: 6 US clinical trials tracked, 4 recruiting.

PrEP is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 4 of them currently open to new participants. The most active sponsor is Johns Hopkins Bloomberg School of Public Health, running 1 of these trials.

Enrollment posture brief

Registry condition prep

OPEN 4 | RECR 67% | LATE 0 | EARLY 0 | RANK #2866 | SPON 1

Nearest open-share peer: Adenocarcinoma of Lung (67% recruiting · 6 trials)

PrEP (this)67%Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%
Open-enrollment share among volume-matched conditions near PrEP

PrEP lists 4 open slots (67% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for PrEP on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. PrEP is recruiting above its size-band peers.

    4 of 6 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates PrEP research.

    Johns Hopkins Bloomberg School of Public Health accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Typical PrEP enrolment sits around 1,000 participants.

    Median target enrolment is 1,000 among the 6 trials that report a genuine target (sentinel values excluded). 1 of those (16.7%) plan for fewer than 100 participants.

  4. PrEP research is mostly interventional.

    5 interventional and 1 observational studies make up this index (83.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Named interventions

Most-linked intervention names on PrEP records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Multilevel Behavioral
1 trials
Patient Level Behavioral
1 trials
Evaluate model of care for HCV-infected adults with on-going opioid misuse Other
1 trials
Peer Navigation Group Behavioral
1 trials
PrOTECT AL Implementation Strategy Other
1 trials
Multicomponent strategy Behavioral
1 trials
Control Behavioral
1 trials
Using PrEP, Doing it for Ourselves (UPDOs) Behavioral
1 trials

US sites by state

Facility locations filed on PrEP trials. A trial with sites in several states counts in each.

Maryland 3 trials
Texas 1 trials
North Carolina 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this PrEP page

6 registered trials, 4 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This PrEP condition card totals 6 registered trials; most-linked intervention Multilevel; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.